MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease
MCLENA-1:一项评估来那度胺治疗阿尔茨海默病引起的轻度认知障碍患者的安全性、耐受性和疗效的II期临床试验
期刊:Open Access Journal of Clinical Trials
影响因子:1.000
doi:10.2147/oajct.s221914
Decourt, Boris; Wilson, Jeffrey; Ritter, Aaron; Dardis, Christopher; DiFilippo, Frank P; Zhuang, Xiaowei; Cordes, Dietmar; Lee, Garam; Fulkerson, Nadia D; St Rose, Tessa; Hartley, Katurah; Sabbagh, Marwan N